detection of therapeutically targetable mutations in nsclc:
Published 3 years ago • 463 plays • Length 56:48Download video MP4
Download video MP3
Similar videos
-
56:48
webinar: detection of therapeutically targetable mutations in nsclc
-
1:37
ngs for the detection of mutations in nsclc
-
1:21
detectability of uncommon egfr mutations in nsclc: ngs versus pcr
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
1:22
the identification of actionable mutations in lung cancer via ctdna
-
5:29
the role of driver mutations in nsclc treatment - 2022 program: lcvl
-
57:49
understanding her2 alterations in advanced non-squamous nsclc
-
7:31
mutation testing to guide alk tki selection in nsclc
-
26:57
segment 2: molecular targets in nsclc
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
4:09
impact of driver mutations in nsclc
-
1:04
ngs provides improved identification of uncommon egfr mutations over pcr in nsclc
-
0:49
the importance of metex14 testing in nsclc
-
1:11
dr. belani discusses driver mutations in nsclc
-
1:11
detecting the met exon 14 skipping mutations in nsclc
-
5:13
current mutation testing in lung cancer
-
49:07
unlock kras g12c for lung cancer treatment decisions
-
1:25
dr. bazhenova on prevalence of ntrk mutations in nsclc
-
1:13
identification of egfr mutations impact overall prognosis in lung cancers